Research

Study to Capture the Treatment with Nusinersen

Nusinersen (Spinraza®) is an approved drug for the treatment of 5q-associated Spinal Muscular Atrophy (SMA). Infants and children treated with Nusinersen may experience cessation of disease

People with ALS Wish for More Robotics in Care

Due to functional impairment, people with Amyotrophic Lateral Sclerosis (ALS) have a high need for nursing care and complex assistive devices provision. The targeted use of robotics – or robotic

3rd Status Meeting for the Register Study on the Care of Patients with ALS

At this year’s German Neurological Association Annual Congress (2018 Neuro Week) Ambulanzpartner hosts the “3rd Status Meeting for the Register Study on the Provision of Assistive Technology